Drug release and bone growth studies of antimicrobial peptide-loaded calcium phosphate coating on titanium

Mehdi Kazemzadeh-Narbat, Shahryar Noordin, Bassam A. Masri, Donald S. Garbuz, Clive P. Duncan, Robert Hancock, Rizhi Wang

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Preventing infection is one of the major challenges in total hip and joint arthroplasty. The main concerns of local drug delivery as a solution have been the evolution of antibiotic-resistant bacteria and the potential inhibition of osseointegration caused by the delivery systems. This work investigated the in vitro drug release, antimicrobial performance, and cytotoxicity, as well as the in vivo bone growth of an antimicrobial peptide loaded into calcium phosphate coated Ti implants in a rabbit model. Two potent AMP candidates (HHC36: KRWWKWWRR, Tet213: KRWWKWWRRC) were first investigated through an in vitro cytotoxicity assay. MTT absorbance values revealed that HHC36 showed much lower cytotoxicity (minimal cytotoxic concentration 200 μg/mL) than Tet 213 (50 lg/mL). The AMP HHC36 loaded onto CaP (34.7 ± 4.2 μg/cm 2) had a burst release during the first few hours followed by a slow and steady release for 7 days as measured spectrophotometrically. The CaP-AMP coatings were antimicrobial against Staphylococcus aureus and Pseudomonas aeruginosa strains in colony-forming units (CFU) in vitro assays. No cytotoxicity was observed on CaP-AMP samples against MG-63 osteoblast-like cells after 5 days in vitro. In a trabecular bone growth in vivo study using cylindrical implants, loading of AMP HHC36 did not impair bone growth onto the implants. Significant bone on-growth was observed on CaP-coated Ti with or without HHC36 loading, as compared with Ti alone. The current AMP-CaP coating thus offers in vivo osteoconductivity to orthopedic implants. It also offers in vitro antimicrobial property, with its in vivo performance to be confirmed in future animal infection models.

LanguageEnglish
Pages1344-1352
Number of pages9
JournalJournal of Biomedical Materials Research - Part B Applied Biomaterials
Volume100 B
Issue number5
DOIs
Publication statusPublished - 1 Jul 2012
Externally publishedYes

Keywords

  • Antimicrobial peptide
  • Bone growth
  • Calcium phosphate coating
  • Orthopedic implants
  • Peri-implant infection
  • Titanium

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials

Cite this

Kazemzadeh-Narbat, Mehdi ; Noordin, Shahryar ; Masri, Bassam A. ; Garbuz, Donald S. ; Duncan, Clive P. ; Hancock, Robert ; Wang, Rizhi. / Drug release and bone growth studies of antimicrobial peptide-loaded calcium phosphate coating on titanium. In: Journal of Biomedical Materials Research - Part B Applied Biomaterials. 2012 ; Vol. 100 B, No. 5. pp. 1344-1352.
@article{379a4a9ebdc34a25917415a0ff7b1413,
title = "Drug release and bone growth studies of antimicrobial peptide-loaded calcium phosphate coating on titanium",
abstract = "Preventing infection is one of the major challenges in total hip and joint arthroplasty. The main concerns of local drug delivery as a solution have been the evolution of antibiotic-resistant bacteria and the potential inhibition of osseointegration caused by the delivery systems. This work investigated the in vitro drug release, antimicrobial performance, and cytotoxicity, as well as the in vivo bone growth of an antimicrobial peptide loaded into calcium phosphate coated Ti implants in a rabbit model. Two potent AMP candidates (HHC36: KRWWKWWRR, Tet213: KRWWKWWRRC) were first investigated through an in vitro cytotoxicity assay. MTT absorbance values revealed that HHC36 showed much lower cytotoxicity (minimal cytotoxic concentration 200 μg/mL) than Tet 213 (50 lg/mL). The AMP HHC36 loaded onto CaP (34.7 ± 4.2 μg/cm 2) had a burst release during the first few hours followed by a slow and steady release for 7 days as measured spectrophotometrically. The CaP-AMP coatings were antimicrobial against Staphylococcus aureus and Pseudomonas aeruginosa strains in colony-forming units (CFU) in vitro assays. No cytotoxicity was observed on CaP-AMP samples against MG-63 osteoblast-like cells after 5 days in vitro. In a trabecular bone growth in vivo study using cylindrical implants, loading of AMP HHC36 did not impair bone growth onto the implants. Significant bone on-growth was observed on CaP-coated Ti with or without HHC36 loading, as compared with Ti alone. The current AMP-CaP coating thus offers in vivo osteoconductivity to orthopedic implants. It also offers in vitro antimicrobial property, with its in vivo performance to be confirmed in future animal infection models.",
keywords = "Antimicrobial peptide, Bone growth, Calcium phosphate coating, Orthopedic implants, Peri-implant infection, Titanium",
author = "Mehdi Kazemzadeh-Narbat and Shahryar Noordin and Masri, {Bassam A.} and Garbuz, {Donald S.} and Duncan, {Clive P.} and Robert Hancock and Rizhi Wang",
year = "2012",
month = "7",
day = "1",
doi = "10.1002/jbm.b.32701",
language = "English",
volume = "100 B",
pages = "1344--1352",
journal = "Journal of Biomedical Materials Research - Part B Applied Biomaterials",
issn = "1552-4973",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

Drug release and bone growth studies of antimicrobial peptide-loaded calcium phosphate coating on titanium. / Kazemzadeh-Narbat, Mehdi; Noordin, Shahryar; Masri, Bassam A.; Garbuz, Donald S.; Duncan, Clive P.; Hancock, Robert; Wang, Rizhi.

In: Journal of Biomedical Materials Research - Part B Applied Biomaterials, Vol. 100 B, No. 5, 01.07.2012, p. 1344-1352.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Drug release and bone growth studies of antimicrobial peptide-loaded calcium phosphate coating on titanium

AU - Kazemzadeh-Narbat, Mehdi

AU - Noordin, Shahryar

AU - Masri, Bassam A.

AU - Garbuz, Donald S.

AU - Duncan, Clive P.

AU - Hancock, Robert

AU - Wang, Rizhi

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Preventing infection is one of the major challenges in total hip and joint arthroplasty. The main concerns of local drug delivery as a solution have been the evolution of antibiotic-resistant bacteria and the potential inhibition of osseointegration caused by the delivery systems. This work investigated the in vitro drug release, antimicrobial performance, and cytotoxicity, as well as the in vivo bone growth of an antimicrobial peptide loaded into calcium phosphate coated Ti implants in a rabbit model. Two potent AMP candidates (HHC36: KRWWKWWRR, Tet213: KRWWKWWRRC) were first investigated through an in vitro cytotoxicity assay. MTT absorbance values revealed that HHC36 showed much lower cytotoxicity (minimal cytotoxic concentration 200 μg/mL) than Tet 213 (50 lg/mL). The AMP HHC36 loaded onto CaP (34.7 ± 4.2 μg/cm 2) had a burst release during the first few hours followed by a slow and steady release for 7 days as measured spectrophotometrically. The CaP-AMP coatings were antimicrobial against Staphylococcus aureus and Pseudomonas aeruginosa strains in colony-forming units (CFU) in vitro assays. No cytotoxicity was observed on CaP-AMP samples against MG-63 osteoblast-like cells after 5 days in vitro. In a trabecular bone growth in vivo study using cylindrical implants, loading of AMP HHC36 did not impair bone growth onto the implants. Significant bone on-growth was observed on CaP-coated Ti with or without HHC36 loading, as compared with Ti alone. The current AMP-CaP coating thus offers in vivo osteoconductivity to orthopedic implants. It also offers in vitro antimicrobial property, with its in vivo performance to be confirmed in future animal infection models.

AB - Preventing infection is one of the major challenges in total hip and joint arthroplasty. The main concerns of local drug delivery as a solution have been the evolution of antibiotic-resistant bacteria and the potential inhibition of osseointegration caused by the delivery systems. This work investigated the in vitro drug release, antimicrobial performance, and cytotoxicity, as well as the in vivo bone growth of an antimicrobial peptide loaded into calcium phosphate coated Ti implants in a rabbit model. Two potent AMP candidates (HHC36: KRWWKWWRR, Tet213: KRWWKWWRRC) were first investigated through an in vitro cytotoxicity assay. MTT absorbance values revealed that HHC36 showed much lower cytotoxicity (minimal cytotoxic concentration 200 μg/mL) than Tet 213 (50 lg/mL). The AMP HHC36 loaded onto CaP (34.7 ± 4.2 μg/cm 2) had a burst release during the first few hours followed by a slow and steady release for 7 days as measured spectrophotometrically. The CaP-AMP coatings were antimicrobial against Staphylococcus aureus and Pseudomonas aeruginosa strains in colony-forming units (CFU) in vitro assays. No cytotoxicity was observed on CaP-AMP samples against MG-63 osteoblast-like cells after 5 days in vitro. In a trabecular bone growth in vivo study using cylindrical implants, loading of AMP HHC36 did not impair bone growth onto the implants. Significant bone on-growth was observed on CaP-coated Ti with or without HHC36 loading, as compared with Ti alone. The current AMP-CaP coating thus offers in vivo osteoconductivity to orthopedic implants. It also offers in vitro antimicrobial property, with its in vivo performance to be confirmed in future animal infection models.

KW - Antimicrobial peptide

KW - Bone growth

KW - Calcium phosphate coating

KW - Orthopedic implants

KW - Peri-implant infection

KW - Titanium

UR - http://www.scopus.com/inward/record.url?scp=84862218354&partnerID=8YFLogxK

U2 - 10.1002/jbm.b.32701

DO - 10.1002/jbm.b.32701

M3 - Article

VL - 100 B

SP - 1344

EP - 1352

JO - Journal of Biomedical Materials Research - Part B Applied Biomaterials

T2 - Journal of Biomedical Materials Research - Part B Applied Biomaterials

JF - Journal of Biomedical Materials Research - Part B Applied Biomaterials

SN - 1552-4973

IS - 5

ER -